Ryoncil: payments to doctors
Payments that named Ryoncil as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $560K
- Providers
- 152
- Transactions
- 207
- Average per transaction
- $2,705
The per-transaction average — $2,705 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 152 providers the average total is $3,683, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mesoblast, Inc. | $559,842 | 100.0% |